Compare EVO & THRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | THRM |
|---|---|---|
| Founded | 1993 | 1991 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2007 | 1996 |
| Metric | EVO | THRM |
|---|---|---|
| Price | $2.01 | $42.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $7.00 | ★ $37.20 |
| AVG Volume (30 Days) | 47.3K | ★ 516.1K |
| Earning Date | 04-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.28 |
| Revenue | N/A | ★ $554,979,000.00 |
| Revenue This Year | $1.37 | $4.96 |
| Revenue Next Year | $10.05 | $7.12 |
| P/E Ratio | ★ N/A | $153.82 |
| Revenue Growth | N/A | ★ 50.16 |
| 52 Week Low | $1.90 | $27.00 |
| 52 Week High | $4.27 | $48.35 |
| Indicator | EVO | THRM |
|---|---|---|
| Relative Strength Index (RSI) | 41.66 | 61.62 |
| Support Level | $1.90 | $34.58 |
| Resistance Level | $3.84 | $48.35 |
| Average True Range (ATR) | 0.05 | 1.72 |
| MACD | 0.05 | -0.13 |
| Stochastic Oscillator | 39.34 | 75.96 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the USA, China, South Korea, Germany, Japan, the Czech Republic, and other countries.